REG - Dr. Martens PLC - Director/PDMR Shareholding

Dr MartensAnnouncement

14/06/2024 13:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240614:nRSN5480Sa&default-theme=true

RNS Number : 5480S  Dr. Martens PLC  14 June 2024

Dr. Martens plc (the "Company")

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial
Responsibility

The Company announces that on 14 June 2024 the following director / person
discharging managerial responsibility ('PDMR') was granted a Performance Share
Award (the "Award") under the Company's Long Term Incentive Plan (the 'LTIP').

 

 PDMR          Number of Shares
 Giles Wilson  1,254,310

 

The Award was made to compensate Giles for loss of long-term incentive schemes
forfeited on leaving his previous employer which he would otherwise have been
eligible to receive. The measures, targets and weightings are aligned to the
annual LTIP award also made and announced by the Company today, 14 June 2024,
and will vest subject to the achievement of earnings per share (50%
weighting), relative total shareholder return (25% weighting), and operating
cash flow conversion (25% weighting) targets over three years and, on vesting,
will be subject to a further two-year holding period.

No consideration was paid for the grant of the Award and no price is payable
on the exercise of the Award.

Full details of the target ranges will be set out in the Directors'
Remuneration Report contained within the 2025 Annual Report & Accounts.

The relevant notification, set out below, is provided in accordance with the
requirements of Article 19 of the Market Abuse Regulation.

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Giles Wilson
 2   Reason for the notification
 a)  Position/status                                              PDMR (Chief Financial Officer)
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Dr. Martens plc
 b)  LEI                                                          213800QPT8YM6NQZPH28
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of GBP 0.01

     Identification code

                                                                  ISIN: GB00BL6NGV24
 b)  Nature of the transaction                                    Grant of performance share award under the

Dr. Martens plc Long-term Incentive Plan
 c)  Price(s) and volume(s)                                       Price(s)  Volume(s)
                                                                  Nil       1,254,310
 d)  Aggregated information

- Aggregated volume
1,254,310

                                                            Nil

- Price
 e)  Date of the transaction                                      2024-06-14
 f)  Place of the transaction                                     Outside a trading venue

d)

Aggregated information

 -  Aggregated volume

 -  Price

 

 1,254,310
 Nil

e)

Date of the transaction

2024-06-14

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUSSARSKUNAAR